 |
The new test center and administration building put in use in Nov., 2011. . |
|
Jiangxi Synergy Pharma Ltd. will participate in CPHI in India. Our booth is M7-2. |
|
April.21-23rd, 2011
Jiangxi Synergy Pharma Ltd. will participate in the 66th API china & interphex china in Chengdu. Our booth is 2E05B. |
|
June 21- 23rd, 2011
Jiangxi Synergy Pharma Ltd. will participate in the 11th CPHI exhibition in shanghai. Our booth is E2E08.
|
|
March.23rd, 2011
The Shanghai branch company was established. Sales department was moved to Shanghai as well, responsible for all the business there.
Address: Rm. 2810, JingAn China Tower, No.1701 Beijing Road West, Shanghai, 200040, China.
Tel: +86-21-6288 6322
Fax:+86-21-6288 0266
E-mail: sales@jxsynergy.com |
|
March. 14—17th, 2011
The superiors of the company participated in DCAT WEEK in New York, USA. |
|
The Phase II major engineering design of Jiangxi Synergy has been finished , with the total investments of 250,000,000RMB. |
|
January.31st, 2011
A year-end summary & appraisal general assembly of Jiangxi Synergy Pharma Ltd has been held, conveying the information that annual targets is successfully completed and obtained a good economic efficiency. Twenty-first excellent staff such as Yuan Junwei, have been awarded as advanced workers or working activists in 2010. |
|
December 19th, 2010
150 students in foreign trade major of Nanchang Institute of Technology have a study tours and visits in our company. |
|
December 11th, 2010
With the leading of the dean, 45 students in pharmaceutical engineering major of Jiangxi Science & Technology Normal University have a study tours and visits in our company. |
|
The new administration building of Jiangxi Synergy broke the earth on Aug.30, with the building area of 5500 square meters and investment budget 15,000,000RMB. |
|
Jiangxi Synergy Pharma Ltd. will participate in CPHI exhibition in Paris during Oct.5-7th, 2010. Our booth is B54 in Hall 2. |
|
Jiangxi Synergy Pharma Ltd. will participate in the 65th API china & interphex china in Suzhou during Nov.10-12th, 2010. Our booth is 3B208b. |
|
Jiangxi Synergy Pharma Ltd. will participate in the 64th API china & interphex china in Harbin in May 18th-20th, 2010. Our booth is B409a.During June 2rd-4th, we will participate in CPHI exhibition in shanghai. Our booth is E2E08. |
|
A year-end summary & appraisal general assembly of Jiangxi Synergy Pharma Ltd has been held on Febuary 10, 2010. Seventeen excellent staff such as Shen Lihua, Liang Meng have been awarded as advanced workers or working activists in 2009. |
|
In company senior staff conference on January 5, 2010, Jiangxi Synergy Pharma Ltd has officially determined that the turnover in the coming 2010 should be double as that of 2009. |
|
GMP Certificate of Venlafaxine HCL has been issued to Jiangxi Synergy Pharma Ltd by SFDA on December 24, 2009, with Certificate No of Gan K0330. |
|
In 2009, Jiangxi Synergy Pharma Ltd has totally received 52 times of on-site audit and visit with the customers from the United States, Canada, Japan, France, Spain, Italy, Korea and so on. |
|
Jiangxi Synergy Pharma Ltd has passed on-site GMP audit by SFDA regarding to the product Venlafaxine HCL on November 6, 2009. |
|
October 13-15, 2009
Jiangxi Synergy Pharma Ltd. will participate in CPHI exhibition in Madrid, our booth is 7E60. |
|
The EHS system of Jiangxi Synergy Pharma Ltd has passed on-site audit by US Pfizer on October27, 2009. |
|
September 25-28, 2009
To celebrate the 60th anniversary of P.R.C, labor union of Jiangxi Synergy Pharma Ltd organized staff from workshops and administrative office to take part in various sportive activities such as basketball, table tennis, tug-of-war, fishing and playing card. |
|
September 6-11, 2009
The Center for Drug Evaluation and Research/ Division of Manufacturing and Product
Quality (CDER/DMPQ), which operates under the U.S Food and Drug Administration
(FDA), conducted a 5-day on-site inspection to Jiangxi Synergy Pharma Ltd. The
cGMP inspection evaluated items including the quality system, facilities, storage,
manufacturing, packaging and labeling, and laboratories. Finally the U.S FDA officer
issued 483 form with only two minor observations. |
|
During the overall inspection on manufacturing safety conducted by authority in September 2009, the EHS performance of Jiangxi Synergy Pharma Ltd got a favorable reception from concerned authority of county. |
API
